Universal anti-influenza vaccines based on viral HA2 and M2e antigens

Number of the records: 1

Title	Universal anti-influenza vaccines based on viral HA2 and M2e antigens
Author	Kostolanský František 1954 SAVVIR ; SAVBIOMED - Virologický ústav SAV ^ORCID
Co-authors	Tomčíková Karolína SAVBIOMED ; SAVVIR - Biomedicínske centrum SAV
	Briestenská Katarína SAVBIOMED ; SAVVIR - Biomedicínske centrum SAV ^ORCID
	Mikušová Miriam SAVBIOMED ; SAVVIR - Biomedicínske centrum SAV
	Varečková Eva 1949 SAVVIR ; SAVBIOMED - Virologický ústav SAV ^ORCID

Source document	Acta Virologica. Vol. 64, no. 4 (2020), p. 417-426
Language	eng - English
Country	SK - Slovak Republic
Document kind	rozpis článkov z periodík (rbx)
Citations	CALZAS, C. - MAO, M. - TURPAUD, M. - VIBOUD, Q. - METTIER, J. - FIGUEROA, T. - BESSIERE, P. - MANGIN, A. - SEDANO, L. - HERVE, P.L. - VOLMER, R. - DUCATEZ, M.F. - BOURGAULT, S. - ARCHAMBAULT, D. - LE GOFFIC, R. - CHEVALIER, C. Immunogenicity and Protective Potential of Mucosal Vaccine Formulations Based on Conserved Epitopes of Influenza A Viruses Fused to an Innovative Ring Nanoplatform in Mice and Chickens. In FRONTIERS IN IMMUNOLOGY. ISSN 1664-3224, NOV 11 2021, vol. 12.
Category	ADDA - Scientific papers in domestic journals registered in Current Contents Connect with IF (impacted)
Category of document (from 2022)	V3 - Vedecký výstup publikačnej činnosti z časopisu
Type of document	článok
Year	2020
Registered in	WOS
Registered in	SCOPUS
Registered in	CCC
DOI	10.4149/av_2020_408

article

	File name	Access	Size	Downloaded	Type	License
	Universal anti-influenza vaccines based on viral HA2 and M2e antigens.pdf	available	741.7 KB	2	Publisher's version

rok	CC	IF	IF Q (best)	JCR Av Jour IF Perc	SJR	SJR Q (best)	CiteScore
	A

rok vydania	rok metriky	IF	IF Q (best)	SJR	SJR Q (best)
2020	2019	0.793	Q4	0.358	Q3

Number of the records: 1